Blood biomarker for Parkinson disease: peptoids.

about

Exploring Erythrocytes as Blood Biomarkers for Alzheimer's Disease.Antibody biomarker for de novo Parkinson disease: attempted validation

P2860

Q47687712-861EB30E-51E6-45D0-BD28-B91D33AAFB66 Q58763516-F6A77E97-ABA7-4CD1-85FB-4F3DF88C1D7E

P2860

Blood biomarker for Parkinson disease: peptoids.

Item

http://www.wikidata.org/entity/Q36182485

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Blood biomarker for Parkinson disease: peptoids.

@ast

Blood biomarker for Parkinson disease: peptoids.

@en

type

Item

label

Blood biomarker for Parkinson disease: peptoids.

@ast

Blood biomarker for Parkinson disease: peptoids.

@en

prefLabel

Blood biomarker for Parkinson disease: peptoids.

@ast

Blood biomarker for Parkinson disease: peptoids.

@en

P1476

Blood biomarker for Parkinson disease: peptoids

@en

P2093

David Karp

http://www.w3.org/2001/XMLSchema#string

Dwight C German

http://www.w3.org/2001/XMLSchema#string

L Steven Brown

http://www.w3.org/2001/XMLSchema#string

Richard B Dewey

http://www.w3.org/2001/XMLSchema#string

Sayed Zaman

http://www.w3.org/2001/XMLSchema#string

Umar Yazdani

http://www.w3.org/2001/XMLSchema#string

P2860

Serum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expression

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

H435-containing immunoglobulin G3 allotypes are transported efficiently across the human placenta: implications for alloantibody-mediated diseases of the newborn.

Seamless bead to microarray screening: rapid identification of the highest affinity protein ligands from large combinatorial libraries

Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries.

The future of blood-based biomarkers for Alzheimer's disease.

Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study

Clinical progression in Parkinson disease and the neurobiology of axons.

IgG subclasses and allotypes: from structure to effector functions.

Levodopa and the progression of Parkinson's disease.

P2888

npjparkd.2016.12

P31

scholarly article

P356

10.1038/NPJPARKD.2016.12

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Linda S. Hynan

P577

2016-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27812535

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

biomarker

P932

5088434

http://www.w3.org/2001/XMLSchema#string

Blood biomarker for Parkinson disease: peptoids.

about

P2860

P2860

Blood biomarker for Parkinson disease: peptoids.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P478

P50

P577

P698

P921

P932